Preview

Избыточный вес и дислипидемия в популяции мужчин 30-49 лет

https://doi.org/10.14341/2071-8713-4801

Полный текст:

Список литературы

1. Константинов В.В., Деев А.Д., Капустина А.В., Шестов Д.Б., Тимофеева Т.Н., Оганов Р.Г. Распросраненность избыточной массы тела и ее связь со смертностью от сердечно-сосудистых и других хронических неинфекционных заболеваний среди мужского населения в городах разных регионов. Кардиология, 2002, № 10: 45-49.

2. Оганов Р.Г., Перова Н.В., Метельская В.А., Олферьев А.М., Мамедов М.Н., Ратникова Л.А., Щельцина Н В. Мелькина О.В., Петриченко И.Е. Абдоминальное ожирение у больных артериальной гипертонией: атерогенные нарушения в состамах транспорта липидов и обмена углеводов. Российский кардиологический журнал, 2001; 31 №5:16-20.

3. Перова Н.В. Суммарный риск ишемической болезни сердца и показания к лечению гиперхолестеринемии (применение Европейских рекомендаций 1994 к Российским условиям). Кардиология, 1996;3: 49-53.

4. Перова Н. В., Метельская В. А., Оганов Р. Г. Патогенетические основы метаболического синдрома как состояния высокого риска атеросклеротических заболеваний. Международный медицинский журнал 2001;7(3):6-10.

5. Balkau B., Charles M.A., Drivsholm T. et al. European Group For The Study Of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002; 28 : 364-376.

6. Beaumont JL., Carlson LA., Cooper GR et al. Classification of hyperlipidemias and hyperlipoproteinemias. Bull.Wld. Health Org. 1970;v.43:891-915.

7. Bjorntrop P. Abdominal obesity and risk. Clin.Exper.Hyper.-Theory and Practice. 1990; A12(5):783-794.

8. Bucolo G., David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin.Chem.1973; 19:476.

9. Burnier M., Brunner HR. Is hyperuricemia a predictor of cardiovascular risk? Curr Opin Nephrol Hypertens 1999;58 (Suppl 1):19-20.

10. Burstein M., Scholnick HR., Morfin R. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J.Lipid Res., 1979; 11:583.

11. Denke M.A. Connections between obesity and dyslipidemia. Curr. Opin. Lipidol. 2001; 12:625-628.

12. Cook S., Weitzman M., Auinger P., Nguyen M., Dietz W.H. Prevalence of a meta- bolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med. 2003; 157: 821-827.

13. De Fronzo R.A., Ferranini E. Insulin resistance: a multifaceted syndrome responsi- ble for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic disease. Diabetes Care 1991;14:173-94.

14. Ducimetriera P., Eschwege E., Papog L. et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population Diabetologia 1980;19:205-10.

15. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by represetatives of eight societies and by invited experts) Eur.Heart J., 2003; 24: 1601-1610.

16. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA,2001; 285: 2486:2497.

17. Friedwald WT., Levy RI., Fredrickson DS.: Estimation of the concentration of low- density lipoprotein cholesterol in plasma without use the preparative ultracentrifuge. Clin.Chem. 18: 499,1972.

18. Haffner SM., Ferranini E., Hazuda HP., Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992;20:38-45.

19. James P.T., Rigby N., Leach R. International Obesity Task Force. The obesity epi- demic, metabolic syndrome and future prevention strategies. Europ. J. Cardiovasc. Prevention and Rehabilitation. 2004; 11:3-8

20. Ley C., Swan J., Godsland I., Walton C., Crook D., Stevehson J. Insulin Resistance, Lipoproteins, Body Fat and Hemostatis in Nonobese Men With Angina and a Normalor Abnormal Coronary Angiogram. JACC Vol .No. 2, February 1994; 377-83.

21. Luscher TF. Endothelial dysfunction as therapeutic target. Eur Heart J 2000; (supll D): D20-D25.

22. Manicardi V., Camellini A., Bellodi G., Coscelli C., Ferrannini E. Evidence for an association of hight blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab, 1986;1302-4.

23. Prevention of coronary heart disease in clinical practice. Recommendations of the second Joint Task Force of European and other Societis on Coronary Prevention. Eur. Heart J., 1998; 19: 1434-1450.

24. Reaven G., Lithell H., Landsberg L. Hypertension and associated metabolic abnor- malities - the role of insulin resistance and the sympatoadrenal system. N. Engl. J. Med 1996; 334:374-81.

25. Roeschlau P., Berndt E., Gruber W. Enzymatische Bestimmung des Gesamtcholesterins in Serum. Zschr. Clin. Chem. 1974; 12:226-230

26. WHO Monica Study data. 1983-86. Women aged 35-64 in Novosibirsk, Russia and Kaunas, Lithuania| IOTF database.


Для цитирования:


Perova N.V., Khadipash L.A., Konstantinov V.V., Olfer'ev A.M., Oganov R.G. Избыточный вес и дислипидемия в популяции мужчин 30-49 лет. Ожирение и метаболизм. 2005;2(1):29-33. https://doi.org/10.14341/2071-8713-4801

For citation:


., ., ., ., . Izbytochnyy ves i dislipidemiya v populyatsii muzhchin 30-49 let. Obesity and metabolism. 2005;2(1):29-33. (In Russ.) https://doi.org/10.14341/2071-8713-4801

Просмотров: 20


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)